The research interests of Prof. Gert Storm (Dept. Pharmaceutics, University of Utrecht) are in the fields of biopharmaceutics and drug targeting. In 1988-1989 he was a visiting scientist at Liposome Technology Inc. in Menlo Park, USA, and visiting assistant professor at the School of Pharmacy, UCSF, San Francisco. In 1990-1991 he was senior research scientist at Pharma Bio-Research Consultancy B.V. in Zuidlaren, for the design, co-ordination and evaluation of clinical pharmacological studies. In 1999, he was appointed adjunct professor at the Royal School of Pharmacy, Copenhagen. From 2009 on, he is Honorary Professor in Biomacromolecular Drug Delivery at the University of Copenhagen. In 2000, he was appointed as professor (Targeted Drug Delivery) at Utrecht University. Form 2012 on, he is also professor (Targeted Therapeutics) at the MIRA institute of the University of Twente.
He is author/co-author of > 400 original articles, reviews and book chapters, in the field of advanced drug delivery/drug targeting. He is member of the editorial (advisory) board of a variety of scientific journals. He is co-ordinator of an Integrated Project (FP6) on targeted nanomedicines (MediTrans) based on the collaboration of 30 european partners and funded by the EC and industry. He is program director of the program Drug Delivery embedded within the recently approved New Nano Initiative (NanoNextNL) strongly sponsored by the dutch government and industry. He is also Principal Investigator of a national industry-academia partnership (HIFU-CHEM) studying the clinical application of MRI-guided high-intensity focused ultrasound (HIFU) to improve cancer chemotherapy.